Vericiguat's Effects on Acute Coronary Syndrome Patients with Diminished Ejection Fraction: Insights from the EVE-ACSrEF Trial

• by Xinying Shi, Anran Zhao, Yi Ding, Lingfeng Gu, Tongtong Yang, Hao Wang, Qiming Wang, Sibo Wang, Liansheng Wang

• February 21, 2026

Digoxin misses heart failure endpoint

Researchers observed fewer worsening heart failure events, but the trial did not establish a statistically significant benefit.

• by Kerri Miller

• October 29, 2026

• 5 min

Seasonal variation and extreme cold exposure in heart failure with mildly reduced ejection fraction

• by Henning Johann Steffen, Michael Behnes, Daniel Duerschmied, Ibrahim Akin, Tobias Schupp

• October 13, 2026

Are Patients Being Referred to Heart Failure Specialists Too Late?

For patients who exhibit common heart failure symptoms and don’t respond to medical therapy, it’s never too early to consider a referral, a Keck Medicine of USC cardiac surgeon advises.

• by

• September 25, 2026

• 5 min